Pharma News - Chemdiv

Norstella, Citeline merge to create $5bn pharma tech firm

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category.

FDA Turns Down Withdrawal Petition for Lung Cancer Drug Approval

The FDA has rejected a citizen petition calling for withdrawal of accelerated approval for Jazz Pharmaceuticals’ and PharmaMar’s Zepzelca (lurbinectedin), a treatment for adults with metastatic...

Invasive malaria mosquito spreading in Africa, researchers warn

'Major threat': Over 126 million people could be a risk if Anopheles stephensi spreads widely in Africa, research has shown.

A new control system for synthetic genes

Using an approach based on CRISPR proteins, MIT researchers have developed a new way to precisely control the amount of a particular protein that is produced in mammalian cells. ...

New approach increases the likelihood of detecting antiphospholipid syndrome

The Geneva University Hospitals (HUG), the University of Geneva (UNIGE) and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholi...

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to ...

Cellular Biomedicine Lung Cancer IND Application Approved

The FDA has approved Cellular Biomedicine’s Investigational New Drug (IND) application for its tumor infiltrating lymphocyte (TIL) drug candidate C-TIL051 for late-stage non-small cell lung cance...

Ancient viral DNA in human genome guards against infections

Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research. ...

C-reactive Protein Score May Predict PD-1 Inhibitor Treatment Efficacy in Intrahepatic Cholangiocarcinoma

The C-reactive protein (CRP) score may be the most effective inflammation-based score to predict the overall survival (OS) of patients with intrahepatic cholangiocarcinoma (ICC) treated with anti-p...

Researcher combines AI and microelectronics to create neural implants that fight brain disorders

Neural implants can help treat brain disorders such as Parkinson's disease and epilepsy by directly modulating abnormal activities — and the University of Toronto's Xilin Liu is working with mic...

$MT-101 Granted Fast Track Designation by FDA for CD5+ Relapsed/Refractory Peripheral T-Cell Lymphoma$

MT-101 Granted Fast Track Designation by FDA for CD5+ Relapsed/Refractory Peripheral T-Cell Lymphoma

Patients with CD5-positive relapsed/refractory peripheral T-cell lymphoma may derive benefit from MT-101, which was granted fast track designation by the FDA.

ITM Gets Fast Track for Radiopharmaceutical Treatment for Neuroendocrine Tumors

ITM Isotope Technologies Munich has received FDA’s Fast Track designation for ITM-11, an investigational radiopharmaceutical for the treatment of gastroenteropancreatic neuroendocrine tumors. ...